发明名称 Diabetic Patients Compliance and Outcomes by Publicizing that Increased Compliance Improves Blood Glucose Control and Outcomes
摘要 Improved outcomes of patients resulting from: continuous monitoring of blood glucose level, other metabolites, food consumption, and preferably, exertion level; and resulting from providing personalized education and other advice on insulin and drug administration, food consumption and timing, and exercise type and intensity, as well as reward test strips which entitle the patient to a discount, rebate or other benefit, are publicized to increase patient compliance with the recommended diet, exercise, and/or testing, drug administration, and improve patient clinical outcomes; or are publicized to recruit new patients into the system, and thereby improve the outcomes and overall health of an increasing proportion of the diabetic patient population. The improved blood glucose level control or other measurable parameters that follow from increased patient compliance and the use of reward test strips can also be publicized to improve patient compliance or recruit more patient into the system.
申请公布号 US2014363794(A1) 申请公布日期 2014.12.11
申请号 US201414474172 申请日期 2014.08.31
申请人 EosHealth, Inc. 发明人 Angelides Kimon J.
分类号 G09B5/02;G09B19/00 主分类号 G09B5/02
代理机构 代理人
主权项 1. A process of increasing diabetic patients' compliance with a recommended diet regimen and publicizing the increased compliance to recruit additional patients, comprising: providing a recommended diet and exercise regimen for the patients to follow for a particular forthcoming period; providing an interactive link between a server and device(s) carried by each of the patients, wherein the device tests a blood sample from the patients for blood glucose level and the device sends the determination of said blood glucose level to the server, and wherein the device(s) or the server queries the patients about prior food consumption and time of food consumption, and where the server, analyzes the blood glucose level test results and query responses, and sends the patient advisory messages about future food consumption and timing of food consumption, and about timing of further testing; monitoring whether patients' compliance with the recommended diet regimen increases or decreases compared to a prior period; determining whether during the monitored period, the patients' clinical outcomes, including survival, cardiovascular disease, cataracts, non-healing wounds and amputation, and tissue necrosis, improves, compared to a prior period, when there is increased patient compliance with the recommended diet regimen during said monitored period, or whether one or more of the patients' clinical outcomes declines when there is decreased patient compliance with the recommended diet regimen during said monitored period; notifying the patients that one or more of the patients' clinical outcomes improve when there is increased patient compliance with the recommended diet regimen, or that one or more of the patients' clinical outcomes declines when there is decreased patient compliance with the recommended diet regimen, in order to encourage compliance by the patients with the recommended diet regimen; and publicizing that clinical outcomes or patient compliance is improved to recruit additional patients.
地址 Houston TX US